NCT05616910View on ClinicalTrials.gov

Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 6, 2025

Primary Completion Date

March 28, 2028

Study Completion Date

March 28, 2028

Conditions
Traumatic Brain Injury
Interventions
DRUG

inhaled nitric oxide

iNO will be provided by ventilator or nasal cannula for 4 hours each day.

Trial Locations (1)

19104

Penn Presbyterian Medical Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER